Susan C Klock1, John X Zhang, Ralph R Kazer. 1. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Feinberg School of Medicine of Northwestern University, Chicago, Illinois, USA. sck318@northwestern.edu
Abstract
OBJECTIVE: To characterize the early experience of a clinical program designed to provide strategies for fertility preservation to female cancer patients about to undergo chemotherapy or radiation therapy. DESIGN: Retrospective chart review; case-control study. SETTING: Academic medical center. PATIENT(S): Sixty-five female cancer patients and 57 age-matched infertility patients. INTERVENTION: Enrollment in a program for fertility preservation. MAIN OUTCOME MEASURE(S): Choice of active participation, fertility preservation option selection, clinical outcomes of patients undergoing oocyte retrieval, attitudes regarding embryo disposition. RESULT(S): Of 65 patients referred to the program, 18 declined to undergo embryo, oocyte, or tissue cryopreservation. Six were found not to be eligible for medical reasons. Of the remaining 41 patients, 35 chose to cryopreserve embryos, four chose to cryopreserve oocytes, and two chose to undergo ovarian tissue freezing. Fewer oocytes were recovered from the embryo cryopreservation group when compared with an age-matched control group, but the mean number of zygotes generated was similar. Attitudes regarding embryo disposition were different between the two groups. No serious clinical sequelae resulted from participation. CONCLUSION(S): Fertility preservation techniques employing available technology may provide safe and practical options to female cancer patients facing chemotherapy or radiation therapy. A significant number of otherwise appropriate participants decline active management. Cancer patients display different attitudes regarding embryo disposition when compared with infertility patients without cancer. Copyright (c) 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
OBJECTIVE: To characterize the early experience of a clinical program designed to provide strategies for fertility preservation to female cancerpatients about to undergo chemotherapy or radiation therapy. DESIGN: Retrospective chart review; case-control study. SETTING: Academic medical center. PATIENT(S): Sixty-five female cancerpatients and 57 age-matched infertilitypatients. INTERVENTION: Enrollment in a program for fertility preservation. MAIN OUTCOME MEASURE(S): Choice of active participation, fertility preservation option selection, clinical outcomes of patients undergoing oocyte retrieval, attitudes regarding embryo disposition. RESULT(S): Of 65 patients referred to the program, 18 declined to undergo embryo, oocyte, or tissue cryopreservation. Six were found not to be eligible for medical reasons. Of the remaining 41 patients, 35 chose to cryopreserve embryos, four chose to cryopreserve oocytes, and two chose to undergo ovarian tissue freezing. Fewer oocytes were recovered from the embryo cryopreservation group when compared with an age-matched control group, but the mean number of zygotes generated was similar. Attitudes regarding embryo disposition were different between the two groups. No serious clinical sequelae resulted from participation. CONCLUSION(S): Fertility preservation techniques employing available technology may provide safe and practical options to female cancerpatients facing chemotherapy or radiation therapy. A significant number of otherwise appropriate participants decline active management. Cancerpatients display different attitudes regarding embryo disposition when compared with infertilitypatients without cancer. Copyright (c) 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Authors: Mi Kyoung Kim; Dong Ryul Lee; Ji Eun Han; You Shin Kim; Woo Sik Lee; Hyung Jae Won; Ji Won Kim; Tae Ki Yoon Journal: J Assist Reprod Genet Date: 2011-11-25 Impact factor: 3.412
Authors: Angela K Lawson; Susan C Klock; Mary Ellen Pavone; Jennifer Hirshfeld-Cytron; Kristin N Smith; Ralph R Kazer Journal: Fertil Steril Date: 2014-08-22 Impact factor: 7.329
Authors: Joseph M Letourneau; Erin E Ebbel; Patricia P Katz; Audra Katz; Wei Z Ai; A Jo Chien; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen Journal: Cancer Date: 2011-09-01 Impact factor: 6.860
Authors: Angela K Lawson; Susan C Klock; Mary Ellen Pavone; Jennifer Hirshfeld-Cytron; Kristin N Smith; Ralph R Kazer Journal: J Psychosoc Oncol Date: 2015
Authors: Saskia F de Roo; Alexandra S Rashedi; Catharina C M Beerendonk; Antoinette Anazodo; Anne Marie de Man; Willianne L D M Nelen; Teresa K Woodruff Journal: Biol Reprod Date: 2017-06-01 Impact factor: 4.285
Authors: K Kyono; T Hashimoto; M Toya; M Koizumi; C Sasaki; S Shibasaki; N Aono; Y Nakamura; R Obata; N Okuyama; Y Ogura; H Igarashi Journal: J Assist Reprod Genet Date: 2017-09-02 Impact factor: 3.412
Authors: Patricia E Hershberger; Lorna Finnegan; Susan Altfeld; Sara Lake; Jennifer Hirshfeld-Cytron Journal: Res Theory Nurs Pract Date: 2013 Impact factor: 0.688
Authors: Alison W Loren; Pamela B Mangu; Lindsay Nohr Beck; Lawrence Brennan; Anthony J Magdalinski; Ann H Partridge; Gwendolyn Quinn; W Hamish Wallace; Kutluk Oktay Journal: J Clin Oncol Date: 2013-05-28 Impact factor: 44.544